Molenaar P, Smolich J J, Russell F D, McMartin L R, Summers R J
Department of Pharmacology, University of Melbourne, Parkville, Victoria, Australia.
J Pharmacol Exp Ther. 1990 Oct;255(1):393-400.
Quantitative autoradiography was used to determine the effects of chronic administration of (-)-isoproterenol (400 micrograms/kg/hr, 7 days) on the distribution and density of beta-1 and beta-2 adrenoceptors in guinea pig atrioventricular conducting system and surrounding regions. X-ray film was exposed to sections of heart labeled with (-)-[125I]-cyanopindolol in the absence or presence of ICI 118,551 (70 nM) to block beta-2 adrenoceptors, CGP 20712A (100 nM) to block beta-1 adrenoceptors or (-)-propranolol (1 microM) to define nonspecific binding. Quantitative autoradiography was performed using computer-assisted image processing and the AVID system. The proportions of beta-1 and beta-2 adrenoceptors were determined by the extent of inhibition of (-)-[125I]cyanopindolol binding by CGP 20712A (100 nM) together with equations which take into account the differing affinities of ligands for beta-1 and beta-2 adrenoceptors. In vehicle (1 mM HCl)-treated animals there was a higher density and proportion of beta-2 adrenoceptors in the atrioventricular node, bundle of His and right and left bundle branches than in myocardium. Chronic administration of (-)-isoproterenol produced marked loss of beta-2 adrenoceptor binding in all regions of the atrioventricular conducting system, surrounding myocardium, cardiac valves and the smooth muscle of the aorta accompanied by less pronounced effects on beta-1 adrenoceptors. Beta-1 adrenoceptors were significantly reduced only in the left bundle branch whereas there were trends toward a reduction in the right bundle branch, bundle of His and an increase in the atrioventricular node. There was no alteration in beta-1 adrenoceptor density in myocardium. Loss of beta adrenoceptor binding produced by (-)-isoproterenol was mainly confined to beta-2 adrenoceptors.
采用定量放射自显影法,以确定长期给予(-)-异丙肾上腺素(400微克/千克/小时,共7天)对豚鼠房室传导系统及周围区域β1和β2肾上腺素能受体分布和密度的影响。在存在或不存在ICI 118,551(70纳摩尔)以阻断β2肾上腺素能受体、CGP 20712A(100纳摩尔)以阻断β1肾上腺素能受体或(-)-普萘洛尔(1微摩尔)以确定非特异性结合的情况下,将X射线胶片暴露于用(-)-[125I]-氰吲哚洛尔标记的心脏切片上。使用计算机辅助图像处理和AVID系统进行定量放射自显影。β1和β2肾上腺素能受体的比例通过CGP 20712A(100纳摩尔)对(-)-[125I]氰吲哚洛尔结合的抑制程度以及考虑配体对β1和β2肾上腺素能受体不同亲和力的方程式来确定。在用载体(1毫摩尔盐酸)处理的动物中,房室结、希氏束以及左右束支中的β2肾上腺素能受体密度和比例高于心肌。长期给予(-)-异丙肾上腺素导致房室传导系统的所有区域、周围心肌、心脏瓣膜和主动脉平滑肌中的β2肾上腺素能受体结合显著丧失,同时对β1肾上腺素能受体的影响较小。仅左束支中的β1肾上腺素能受体显著减少,而右束支、希氏束有减少趋势,房室结有增加趋势。心肌中的β1肾上腺素能受体密度没有改变。(-)-异丙肾上腺素导致的β肾上腺素能受体结合丧失主要局限于β2肾上腺素能受体。